REGENXBIO INC (RGNX)

US75901B1070 - Common Stock

16.01  -0.22 (-1.36%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
86.73M90.24M112.70M470.30M154.60M
Cost Of Goods
37.42M37.21M54.50M51.80M35.70M
Gross Profit
49.31M53.03M58.20M418.50M118.90M
Operating Expenses
313.08M321.16M321.10M258.60M238.10M
Research and Development
228.63M232.27M242.50M181.40M166.30M
Selling, General, and Administrative Expenses
84.17M88.49M85.30M79.30M63.80M
Operating Income
-263.76M-268.13M-262.90M160.00M-119.20M
Interest Income/Expense
5.50M4.48M-17.50M-18.70M13.20M
Income Before Taxes
-260.37M-263.65M-280.40M141.20M-106.00M
Income Tax
N/A-152.00K-100.00K13.40M5.20M
Net Income
-260.22M-263.49M-280.30M127.80M-111.30M
EBITDA
-246.47M-250.81M-250.00M169.60M-110.80M
 
Per Share Data
EPS Diluted Total Ops
-5.88-6.02-6.502.91-2.98
Non GAAP EPS
-5.83-6.03-6.502.74-2.80
 
Statistics
Gross Profit Margin
56.86%58.76%51.64%88.99%76.91%
Profit Margin
-300.02%-291.99%-248.71%27.17%-71.99%
Operating Profit Margin
-304.10%-297.12%-233.27%34.02%-77.10%

All data in USD

Charts